BiondVax Pharmaceuticals Q1 EPS $(0.01) Up From $(0.04) YoY
BiondVax Pharmaceuticals (NASDAQ:BVXV) reported quarterly losses of $(0.01) per share. This is a 87.5 percent increase over losses of $(0.04) per share from the same period last year.